Galena Biopharma to Present at the Oppenheimer 23rd Annual Healthcare Conference
Galena Biopharma to Present at the Oppenheimer 23rd Annual Healthcare Conference LAKE OSWEGO, Ore., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will present a corporate overview at the Oppenheimer 23^rd Annual Healthcare Conference. The presentation will take place on Thursday, December 13, 2012 at 3:55 p.m. EST at The Waldorf-Astoria Hotel in New York, NY. The presentation will be webcast and available on the Company's website at http://investors.galenabiopharma.com/events.cfm. About Galena Biopharma Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com. The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647 CONTACT: Madeline Hatton Toll free: +1 (855) 855-GALE (4253), ext. 109 email@example.com or Remy Bernarda IR Sense, LLC +1 (503) 400-6995 firstname.lastname@example.org Galena Biopharma, Inc.